The Journal of Pathology

Cover image for Vol. 230 Issue 2

June 2013

Volume 230, Issue 2

Pages 129–238

  1. Invited Commentary

    1. Top of page
    2. Invited Commentary
    3. Invited Review
    4. Invited Perspective
    5. Original Papers
  2. Invited Review

    1. Top of page
    2. Invited Commentary
    3. Invited Review
    4. Invited Perspective
    5. Original Papers
    1. Tumour necrosis factor in infectious disease (pages 132–147)

      John P Waters, Jordan S Pober and John R Bradley

      Version of Record online: 13 MAY 2013 | DOI: 10.1002/path.4187

  3. Invited Perspective

    1. Top of page
    2. Invited Commentary
    3. Invited Review
    4. Invited Perspective
    5. Original Papers
    1. You have full text access to this OnlineOpen article
  4. Original Papers

    1. Top of page
    2. Invited Commentary
    3. Invited Review
    4. Invited Perspective
    5. Original Papers
    1. Biallelic DICER1 mutations occur in Wilms tumours (pages 154–164)

      MK Wu, N Sabbaghian, B Xu, S Addidou-Kalucki, C Bernard, D Zou, AE Reeve, MR Eccles, C Cole, CS Choong, A Charles, TY Tan, DM Iglesias, PR Goodyer and WD Foulkes

      Version of Record online: 13 MAY 2013 | DOI: 10.1002/path.4196

    2. Nucleotide resolution analysis of TMPRSS2 and ERG rearrangements in prostate cancer (pages 174–183)

      Christopher Weier, Michael C Haffner, Timothy Mosbruger, David M Esopi, Jessica Hicks, Qizhi Zheng, Helen Fedor, William B Isaacs, Angelo M. De Marzo, William G Nelson and Srinivasan Yegnasubramanian

      Version of Record online: 13 MAY 2013 | DOI: 10.1002/path.4186

    3. Metallothionein 1 h tumour suppressor activity in prostate cancer is mediated by euchromatin methyltransferase 1 (pages 184–193)

      Yu-Chen Han, Zhong-Liang Zheng, Ze-Hua Zuo, Yan P Yu, Rui Chen, George C Tseng, Joel B Nelson and Jian-Hua Luo

      Version of Record online: 13 MAY 2013 | DOI: 10.1002/path.4169

    4. Epigenetic regulation of DACT2, a key component of the Wnt signalling pathway in human lung cancer (pages 194–204)

      Yan Jia, Yunsheng Yang, Malcolm V Brock, Qimin Zhan, James G Herman and Mingzhou Guo

      Version of Record online: 13 MAY 2013 | DOI: 10.1002/path.4073

    5. Essential role of stem cell factor–c-Kit signalling pathway in bleomycin-induced pulmonary fibrosis (pages 205–214)

      Lin Ding, Vladilsav Dolgachev, Zhuang Wu, Tianju Liu, Taku Nakashima, Zhe Wu, Matthew Ullenbruch, Nicholas W Lukacs, Zidi Chen and Sem H Phan

      Version of Record online: 3 APR 2013 | DOI: 10.1002/path.4177

    6. Advanced glycation end product Nε-carboxymethyllysine induces endothelial cell injury: the involvement of SHP-1-regulated VEGFR-2 dephosphorylation (pages 215–227)

      Shing Hwa Liu, Wayne Huey Herng Sheu, Maw Rong Lee, Wen Jane Lee, Yu Chiao Yi, Tzung Jie Yang, Jen Fon Jen, Hung Chuan Pan, Chin Chang Shen, Wen Bao Chen, Hsing Ru Tien and Meei Ling Sheu

      Version of Record online: 12 MAR 2013 | DOI: 10.1002/path.4045

    7. Long pentraxin-3 as an epithelial–stromal fibroblast growth factor-targeting inhibitor in prostate cancer (pages 228–238)

      Roberto Ronca, Patrizia Alessi, Daniela Coltrini, Emanuela Di Salle, Arianna Giacomini, Daria Leali, Michela Corsini, Mirella Belleri, Chiara Tobia, Cecilia Garlanda, Elisa Bonomi, Regina Tardanico, William Vermi and Marco Presta

      Version of Record online: 13 MAY 2013 | DOI: 10.1002/path.4181

SEARCH

SEARCH BY CITATION